You can buy or sell Quidel and other stocks, options, ETFs, and crypto commission-free!
Quidel Corp. engages in the development, manufacture, and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. Read More The products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA.
San Diego, California
52 Week High
52 Week Low
Immunoassay Market Size Worth $25.41 Billion by 2025 | CAGR: 5.0%: Grand View Research, Inc.
SAN FRANCISCO, March 6, 2019 /PRNewswire/ -- The global immunoassay market size is expected to reach USD 25.41 billion by 2025, according to a new report by Grand View Research, Inc.
Yahoo FinanceMar 4
What Are Analysts Saying About Quidel Corporation’s (NASDAQ:QDEL) Growth?
Looking at Quidel Corporation’s (NASDAQ:QDEL) earnings update on 31 December 2018, analysts seem cautiously optimistic, as a 21% increase in profits is expected in the upcoming year, though this is relatively lower than the previous 5-year average earnings growth of 59%. Currently with trailing-twelve-month earnings of US$74m, we can expect this to reach US$90m by 2020. Below is a brief commentary around Quidel’s earnings outlook going forward, which may give you a sense of market sentiment for the company.
Markets InsiderFeb 26
Quidel to Present at Upcoming Conferences
Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it will present at the following upcoming conferences: Raymond James & Associates 40 th Annual Institutional Investors Conference to be held at the J.W. Marriott Grande Lakes hotel in Orlando, Florida on Wednesday, March 6, 2019 at 12:10 p.m. Eastern Time (9:10 a.m. Pacific Time). Annual Institutional Investors Conference to be held at t...
Expected May 7, After Hours